These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

898 related items for PubMed ID: 26376292

  • 1. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    de Cuba EM, Snaebjornsson P, Heideman DA, van Grieken NC, Bosch LJ, Fijneman RJ, Belt E, Bril H, Stockmann HB, Hooijberg E, Punt CJ, Koopman M, Nagtegaal ID, Coupé VH, Carvalho B, Meijer GA.
    Int J Cancer; 2016 Mar 01; 138(5):1139-45. PubMed ID: 26376292
    [Abstract] [Full Text] [Related]

  • 2. The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer.
    Lin CC, Lin JK, Lin TC, Chen WS, Yang SH, Wang HS, Lan YT, Jiang JK, Yang MH, Chang SC.
    J Surg Oncol; 2014 Sep 01; 110(4):451-7. PubMed ID: 24964758
    [Abstract] [Full Text] [Related]

  • 3. Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials.
    Taieb J, Sinicrope FA, Pederson L, Lonardi S, Alberts SR, George TJ, Yothers G, Van Cutsem E, Saltz L, Ogino S, Kerr R, Yoshino T, Goldberg RM, André T, Laurent-Puig P, Shi Q.
    Ann Oncol; 2023 Nov 01; 34(11):1025-1034. PubMed ID: 37619846
    [Abstract] [Full Text] [Related]

  • 4. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
    Taieb J, Le Malicot K, Shi Q, Penault-Llorca F, Bouché O, Tabernero J, Mini E, Goldberg RM, Folprecht G, Luc Van Laethem J, Sargent DJ, Alberts SR, Emile JF, Laurent Puig P, Sinicrope FA.
    J Natl Cancer Inst; 2017 May 01; 109(5):. PubMed ID: 28040692
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients.
    Won DD, Lee JI, Lee IK, Oh ST, Jung ES, Lee SH.
    BMC Cancer; 2017 Jun 05; 17(1):403. PubMed ID: 28583095
    [Abstract] [Full Text] [Related]

  • 8. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
    Ooki A, Akagi K, Yatsuoka T, Asayama M, Hara H, Takahashi A, Kakuta M, Nishimura Y, Yamaguchi K.
    J Surg Oncol; 2014 Dec 05; 110(8):982-8. PubMed ID: 25154726
    [Abstract] [Full Text] [Related]

  • 9. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.
    Roth AD, Tejpar S, Delorenzi M, Yan P, Fiocca R, Klingbiel D, Dietrich D, Biesmans B, Bodoky G, Barone C, Aranda E, Nordlinger B, Cisar L, Labianca R, Cunningham D, Van Cutsem E, Bosman F.
    J Clin Oncol; 2010 Jan 20; 28(3):466-74. PubMed ID: 20008640
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
    Pai RK, Jayachandran P, Koong AC, Chang DT, Kwok S, Ma L, Arber DA, Balise RR, Tubbs RR, Shadrach B, Pai RK.
    Am J Surg Pathol; 2012 May 20; 36(5):744-52. PubMed ID: 22314188
    [Abstract] [Full Text] [Related]

  • 12. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.
    Seppälä TT, Böhm JP, Friman M, Lahtinen L, Väyrynen VM, Liipo TK, Ristimäki AP, Kairaluoma MV, Kellokumpu IH, Kuopio TH, Mecklin JP.
    Br J Cancer; 2015 Jun 09; 112(12):1966-75. PubMed ID: 25973534
    [Abstract] [Full Text] [Related]

  • 13. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
    Nam SK, Yun S, Koh J, Kwak Y, Seo AN, Park KU, Kim DW, Kang SB, Kim WH, Lee HS.
    PLoS One; 2016 Jun 09; 11(3):e0151865. PubMed ID: 26991109
    [Abstract] [Full Text] [Related]

  • 14. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
    Taieb J, Kourie HR, Emile JF, Le Malicot K, Balogoun R, Tabernero J, Mini E, Folprecht G, Van Laethem JL, Mulot C, Bouché O, Aparicio T, Michel P, Thaler J, Bridgewater J, Van Cutsem E, Perkins G, Lepage C, Salazar R, Laurent-Puig P, Pan-European Trials in Alimentary Tract Cancer (PETACC)-8 Investigators.
    JAMA Oncol; 2018 Jul 12; 4(7):e173695. PubMed ID: 29167892
    [Abstract] [Full Text] [Related]

  • 15. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
    Sinicrope FA, Shi Q, Smyrk TC, Thibodeau SN, Dienstmann R, Guinney J, Bot BM, Tejpar S, Delorenzi M, Goldberg RM, Mahoney M, Sargent DJ, Alberts SR.
    Gastroenterology; 2015 Jan 12; 148(1):88-99. PubMed ID: 25305506
    [Abstract] [Full Text] [Related]

  • 16. Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer.
    Birgisson H, Edlund K, Wallin U, Påhlman L, Kultima HG, Mayrhofer M, Micke P, Isaksson A, Botling J, Glimelius B, Sundström M.
    BMC Cancer; 2015 Mar 14; 15():125. PubMed ID: 25884297
    [Abstract] [Full Text] [Related]

  • 17. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Fujiyoshi K, Yamamoto G, Takahashi A, Arai Y, Yamada M, Kakuta M, Yamaguchi K, Akagi Y, Nishimura Y, Sakamoto H, Akagi K.
    Oncol Rep; 2017 Feb 14; 37(2):785-792. PubMed ID: 28000889
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer.
    Kadowaki S, Kakuta M, Takahashi S, Takahashi A, Arai Y, Nishimura Y, Yatsuoka T, Ooki A, Yamaguchi K, Matsuo K, Muro K, Akagi K.
    World J Gastroenterol; 2015 Jan 28; 21(4):1275-83. PubMed ID: 25632202
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer.
    Chouhan H, Sammour T, L Thomas M, W Moore J.
    Asia Pac J Clin Oncol; 2019 Feb 28; 15(1):69-74. PubMed ID: 30421554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.